Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2012
05/31/2012US20120136053 Copepod oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders
05/31/2012US20120136052 Substituted acylanilides and methods of use thereof
05/31/2012US20120136046 Method of treating age related disorders
05/31/2012US20120136034 Fatty acids as anti-inflammatory agents
05/31/2012US20120136031 P38map kinase inhibitor
05/31/2012US20120136026 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120136018 Quinolines
05/31/2012US20120136003 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
05/31/2012US20120136001 Substituted oxindole derivatives, medicaments containing the latter and use thereof
05/31/2012US20120136000 Tri-cyclic pyrazolopyridine kinase inhibitors
05/31/2012US20120135994 Inhibitors of human phosphatidylinositol 3-kinase delta
05/31/2012US20120135982 5HT2c RECEPTOR MODULATORS
05/31/2012US20120135979 Pyrazinooxazepine derivatives
05/31/2012US20120135975 Substituted Esters as Cannabinoid-1 Receptor Modulators
05/31/2012US20120135958 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120135952 Butyric acid salt of n,n-dimethyl imidocarbon imidic diamide, method of preparing same, and pharmaceutical compositions and combinations containing same
05/31/2012US20120135941 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
05/31/2012US20120135927 Bone morphogenetic proteins for the treatment of insulin resistance
05/31/2012US20120135923 Use of Melanocortins to Treat Dyslipidemia
05/31/2012US20120135922 Modified exendins and exendin agonists
05/31/2012US20120135921 Tripetide boronic acid or boronic ester, preparative method and use thereof
05/31/2012US20120135920 Preparation Comprising Insulin, Nicotinamide and an Amino Acid
05/31/2012US20120135919 Polymer-drug conjugates
05/31/2012US20120135918 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
05/31/2012US20120135916 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
05/31/2012US20120135068 Liposome-encapsulated glutathione for oral administration
05/31/2012US20120135041 Immunosuppressor based on the blockage of tcr-nck interaction
05/31/2012US20120135022 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
05/31/2012US20120135016 Induction of neurogenesis and stem cell therapy in combination with copolymer 1
05/31/2012US20120135015 Induction of Pancreatic Stem Cells by Transient Overexpression of Reprogramming Factors and PDX1 Selection
05/31/2012US20120135007 Anti-LPS Enriched Immunoglobulin Preparations For The Treatment And/Or Prophylaxis Of A Pathologic Disorder
05/31/2012US20120134998 Secreted ap2 and methods of inhibiting same
05/31/2012US20120134985 Methods for modulating metabolic and circadian rhythms
05/31/2012US20120134977 Prodrugs containing albumin binding probe
05/31/2012US20120134976 Oral formulations for counteracting effects of aging
05/31/2012US20120134973 Novel use of probiotics
05/31/2012US20120134966 Embryonic stem cell specific micrornas promote induced pluripotency
05/31/2012US20120134929 Treatment of macrophage-related disorders
05/31/2012DE102005023301B4 Pharmazeutische Zusammensetzung enthaltend Gestagene und/oder Estrogene und 5-Methyl-(6S)-tetrahydrofolat A pharmaceutical composition comprising progestins and / or estrogens and 5-methyl- (6S) -tetrahydrofolate
05/31/2012CA2818050A1 Bicyclic gpr119 modulators
05/31/2012CA2818007A1 Multicomponent system of rosuvastatin calcium salt and sorbitol
05/31/2012CA2814231A1 4- (5-cyano-pyrazol-1-yl) -piperidine derivatives as gpr 119 modulators
05/30/2012EP2458005A1 Fgf21 cis-element binding substance
05/30/2012EP2457918A2 Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes
05/30/2012EP2457897A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
05/30/2012EP2457573A1 Methods of use of glycomimetics with replacements for hexoses and N-Acetyl hexosamines
05/30/2012EP2456862A2 Differentiation of human embryonic stem cells
05/30/2012EP2456858A2 Differentiation of human embryonic stem cells
05/30/2012EP2456767A1 Pyridone glucokinase activators
05/30/2012EP2456754A1 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway
05/30/2012EP2456432A1 Methods and compositions to reduce oxidative stress
05/30/2012EP2303297B1 Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism
05/30/2012EP2055703B1 Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and pharmaceutical comprising the compound
05/30/2012EP2021365B1 A ghrelin splice variant for use in the prevention or treatment of high cholesterol levels
05/30/2012EP1940842B1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
05/30/2012EP1797093B1 Novel 3-methyl-7-butinyl-xanthines, production thereof, and use thereof as medicaments
05/30/2012EP1702919B1 Novel 2-heteroaryl-substituted benzimidazole derivative
05/30/2012CN1997386B Methods of treating type I diabetes by blocking VEGF-mediated activity
05/30/2012CN1774420B Process for the preparation of N-substituted 2-cyanopyrrolidines
05/30/2012CN1659154B Method of preparing amine stereoisomers
05/30/2012CN102482643A 人胚胎干细胞的分化 Differentiation of human embryonic stem cells
05/30/2012CN102482640A 人胚胎干细胞的分化 Differentiation of human embryonic stem cells
05/30/2012CN102482339A Methods for increasing thermogenic adipocytes
05/30/2012CN102482315A 肝x受体激动剂 Liver x receptor agonist
05/30/2012CN102482268A 2 -Aminodihydro [1, 3] Thiazines As Bace 2 Inhibitors For The Treatment Of Diabetes
05/30/2012CN102482267A 作为葡萄糖激酶(gk)活化剂的取代苯甲酰胺衍生物 As a glucokinase-substituted benzamide derivative (gk) activators
05/30/2012CN102482235A 苯并噁嗪酮化合物的结晶 Crystalline compounds benzoxazinone
05/30/2012CN102481373A Drug fusions and conjugates
05/30/2012CN102481362A 表皮生长因子受体(egfr)与蛋白酶活化受体2(par2)对肠道通透性的调节 Epidermal growth factor receptor (egfr) and protease-activated receptor 2 (par2) on the regulation of intestinal permeability
05/30/2012CN102481338A Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
05/30/2012CN102481337A 用于治疗糖尿病的调节mg29的组合物和方法 Compositions and methods for treating diabetes for adjusting mg29
05/30/2012CN102481322A Bacterial compositions for prophylaxis and treatment of degenerative disease
05/30/2012CN102481305A 磷脂酰胆碱的经皮组合物及其制备方法 Phosphatidylcholine percutaneous composition and its preparation method
05/30/2012CN102481303A Glucose metabolism-improving agent and glucose metabolism-improving composition
05/30/2012CN102481276A Chemosensory receptor ligand-based therapies
05/30/2012CN102481271A 利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗代谢障碍的方法 AME use change agents within the multi-dimensional cellular and molecular methods or environmental impact agent for treating metabolic disorders
05/30/2012CN102481254A Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes
05/30/2012CN102481009A 包含外源性核苷酸的营养组合物 The nutritional composition comprises an exogenous nucleotide
05/30/2012CN102477453A 一种从黄杞叶中制备花旗松素单体的方法及用途 A leaf from the Engelhardtia prepared Taxifolin monomers and uses
05/30/2012CN102477421A 一种激酶蛋白Akt1基因条件性敲除小鼠的建立及用途 A protein kinase Akt1 gene conditional knockout mice to establish and use
05/30/2012CN102477033A 苯并噻酚类化合物及其在制备预防和/或治疗乳腺癌骨质疏松症药物中的用途 Benzothiazole phenolic compounds and their preparation for prevention and / or treatment of osteoporosis, breast cancer medicament for use in
05/30/2012CN102477032A 2-cyclopropyl-4-substituted-phenoxy-quinoline derivatives, and its preparation method, intermediate and application
05/30/2012CN102477017A 四氢萘衍生物及其在制备预防和/或治疗乳腺癌骨质疏松症药物中的用途 Tetrahydronaphthalene derivatives and the prevention and / or treatment of osteoporosis, breast cancer in the manufacture of a medicament
05/30/2012CN102477013A 一种可抑制人1型11β-羟基类固醇脱氢酶活性的姜黄素类化合物的制备及其应用 That inhibits people with type 1 11β- hydroxysteroid dehydrogenase activity of preparation and application of curcuminoids
05/30/2012CN102477010A 吲哚衍生物及其在制备预防和/或治疗乳腺癌骨质疏松症药物中的用途 Indole derivatives and their preparation for prevention and / or use in the treatment of osteoporosis, breast cancer medicament
05/30/2012CN102475842A 治疗糖尿病制剂 Preparations for treating diabetes
05/30/2012CN102475819A 植物溶血片 Plants hemolysis sheet
05/30/2012CN102475818A 椒目三子汤 Zanthoxylum three sons soup
05/30/2012CN102475796A 一种治疗糖尿病的药物 Drugs for treating diabetes
05/30/2012CN102475788A 一种兽用止痢散 One kind of veterinary Zhilishen scattered
05/30/2012CN102475733A 一种红花油的制备方法 Preparation of one kind of safflower oil
05/30/2012CN102475732A 吃的香健胃消食减肥丸 Hong Jianweixiaoshi eat slimming pills
05/30/2012CN102475731A 治疗小儿(轮状病毒、痢疾及疟疾)疾病分子苗药原料 Treatment of children (rotavirus, diarrhea and malaria) disease molecular Miao medicine raw materials
05/30/2012CN102475725A 降糖明目丸 Hypoglycemic eyesight pill
05/30/2012CN102475724A 视网膜保护片 Retinal protective sheet
05/30/2012CN102475721A Probiotics oral liquid for health promotion
05/30/2012CN102475714A 壳寡糖单一化合物在免疫增强药物中的应用 Oligochitosan single compounds in immune-enhancing drugs in
05/30/2012CN102475712A Pharmaceutical composition used for preventing and treating diabetes and its complications
05/30/2012CN102475697A 注射用门冬氨酸鸟氨酸的制备 Injectable preparation with ornithine aspartate
05/30/2012CN102475688A 普罗布考口服纳米固体制剂及其制备方法 Probucol oral solid formulation and preparation method of nano